Jnj Q3 Earnings 2024. (nyse:nke) today reported fiscal 2024 financial results for its third quarter ended february 29, 2024. Quarter 2024 quarterly earnings call.
The biopharmaceutical company reported $0.10 earnings per share (eps) for the quarter,. Johnson & johnson (jnj) q3 earnings and revenues surpass estimates.
Johnson &Amp; Johnson Reports Q3 2022 Results.
The operational sales growth, a metric excluding currency.
Reported Sales Growth Of 1.9% To $23.8 Billion With Operational.
Overall, the average positive earnings surprise stood at 15.58% during the past four quarters.
Pfizer Last Posted Its Quarterly Earnings Data On January 30Th, 2024.
Images References :
(Nyse:nke) Today Reported Fiscal 2024 Financial Results For Its Third Quarter Ended February 29, 2024.
Quarter 2024 quarterly earnings call.
3Q23 Other Financial Disclosures (Pdf) 3Q23 Other Financial Disclosures (Excel).
See more » johnson & johnson (jnj) is set to release its q4 2023 earnings, with investors eager to hear its plans for dealing with talc.
Third Quarter Revenues Were Slightly Up On Both A.